Studies have shown that patients receiving human serum albumin therapy during Linezolid treatment have a low incidence of thrombocytopenia, and there is a significant negative correlation between serum albumin concentration and Linezolid-induced thrombocytopenia (Zhang et al., 2023). The gene discussed is ALB; the disease is Thrombocytopenia.